Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04169542 · ClinicalTrials.gov registry record
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
A clinical trial of Invasive Breast Carcinoma and COVID-19 Infection, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 600
- Enrollment target
- 4
- Study locations
NCT04169542: Recruiting study of Invasive Breast Carcinoma and COVID-19 Infection, sponsored by M.D. Anderson Cancer Center.
NCT04169542 is a study of Invasive Breast Carcinoma and COVID-19 Infection that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 600 participants, above the 472-participant average among 45 other Invasive Breast Carcinoma trials with a reported enrollment target (27% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04169542, a study of Invasive Breast Carcinoma and COVID-19 Infection, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction. This may help researchers demonstrate the financial consequences of undergoing breast surgery.
Primary Outcome
Will be measured by the Comprehensive Score for financial Toxicity questionnaire. Summary statistics including mean, standard deviation, median, and range for continuous variables, and frequency count and percentage for categorical variables will be provided. Various subgroup analyses may occur. In these cases, continuous variables will be compared using the two-sample t-test and categorical variables will be compared using chi-squared test or Fisher's exact test. Multivariate regression analysi
Conditions Studied
Interventions
- OTHER Questionnaire Administration
Study Locations (4)
Texas
- MD Anderson in The Woodlands - Conroe
- M D Anderson Cancer Center - Houston
- MD Anderson League City - League City
- MD Anderson in Sugar Land - Sugar Land
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2019-05-21 |
| Est. Completion | 2026-03-31 |
What NCT04169542 shows while recruiting
NCT04169542 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 472-participant average among 45 other Invasive Breast Carcinoma trials with a reported enrollment target (27% higher).
The record links to 4 conditions, with Invasive Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire Administration is the first listed.
NCT04169542 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04169542 about?
NCT04169542 is a clinical study titled "Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery". This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on we...
What is the current status of trial NCT04169542?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2019-05-21. Estimated completion is 2026-03-31.
What conditions does trial NCT04169542 study?
This clinical trial studies the following conditions: Invasive Breast Carcinoma, COVID-19 Infection, Breast Ductal Carcinoma In Situ, Hereditary Breast Carcinoma.
What interventions are being tested in trial NCT04169542?
The interventions under investigation include: Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT04169542?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04169542 being conducted?
This trial has 4 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Invasive Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04169542's enrollment target sits among peer trials
600 12th of 45 higher than 34 of 45 other Invasive Breast Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Invasive Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
RECRUITING · Phase 1
-
Breast Cancer Survivorship Biorepository
RECRUITING
-
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
RECRUITING
-
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
RECRUITING · NA
-
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
RECRUITING · Phase 3
-
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI